Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Non-Current Assets (2020 - 2025)

Historic Non-Current Assets for Molecular Partners Ag (MOLN) over the last 6 years, with Q3 2025 value amounting to $3987.7.

  • Molecular Partners Ag's Non-Current Assets fell 2617.61% to $3987.7 in Q3 2025 from the same period last year, while for Sep 2025 it was $3987.7, marking a year-over-year decrease of 2617.61%. This contributed to the annual value of $4827.6 for FY2024, which is 9992.73% down from last year.
  • Per Molecular Partners Ag's latest filing, its Non-Current Assets stood at $3987.7 for Q3 2025, which was down 2617.61% from $4452.3 recorded in Q2 2025.
  • Molecular Partners Ag's 5-year Non-Current Assets high stood at $9.2 million for Q4 2021, and its period low was $3987.7 during Q3 2025.
  • Its 5-year average for Non-Current Assets is $2.8 million, with a median of $7684.3 in 2022.
  • As far as peak fluctuations go, Molecular Partners Ag's Non-Current Assets tumbled by 897.83% in 2023, and later crashed by 9992.7% in 2024.
  • Molecular Partners Ag's Non-Current Assets (Quarter) stood at $9.2 million in 2021, then dropped by 15.25% to $7.8 million in 2022, then fell by 14.73% to $6.6 million in 2023, then plummeted by 99.93% to $4848.0 in 2024, then decreased by 17.75% to $3987.7 in 2025.
  • Its Non-Current Assets was $3987.7 in Q3 2025, compared to $4452.3 in Q2 2025 and $4609.2 in Q1 2025.